Lilly's $3.8 Billion Vaccine Bets: A Quiet Shift Now
Lilly's heavy reliance on GLP-1 drugs has investors watching as the company bets $3.8B on vaccines. This analysis exp...
Explore various resources to find financial education workshops in your area. Enhance your financial literacy and skills.
16,955 articlesLilly's heavy reliance on GLP-1 drugs has investors watching as the company bets $3.8B on vaccines. This analysis exp...
The Global X AI & Technology ETF (AIQ) delivered a six-month surge that helped some investors turn $10,000 into $13,4...
A massive AI-driven data center build-out is changing how investors think about tech stocks. This piece explains the ...
MapleStory Universe opens space and launches a global game jam with a $60,000 NXPC prize, marking a major milestone f...
A 56-year-old hospital administrator faces a potential half-million-dollar federal tax bill on an inherited $1.8 mill...
As SPAR Group prepares to report Q4 2025 results, investors seek clarity on growth, margins, and cash flow. This guid...
Alphabet's plan to issue new stock could dilute existing holders. This deep dive explains what that means for investo...
A decade of reinvested dividends can turn a modest $1,000 investment in Chevron into a much larger nest egg, even as ...
June data show existing home sales beat forecasts, signaling ongoing demand strength in 2026. The numbers point to st...
June markets stay choppy as Aurora Innovation slides on Uber stake actions. This guide breaks down what it means for ...
Fidelity’s technology-focused ETF has sprinted ahead in 2026, delivering sizeable gains while the broad market stagna...
A market dip in the chip sector created a rare buying opportunity. This guide features three thoughtful picks to own ...